Published in Nephrology (Carlton) on December 01, 2009
Diets and enteral supplements for improving outcomes in chronic kidney disease. Nat Rev Nephrol (2011) 1.42
Management of protein-energy wasting in non-dialysis-dependent chronic kidney disease: reconciling low protein intake with nutritional therapy. Am J Clin Nutr (2013) 1.27
Metabolic engineering of Corynebacterium glutamicum for 2-ketoisovalerate production. Appl Environ Microbiol (2010) 1.01
High body mass index reduces glomerular filtration rate decline in type II diabetes mellitus patients with stage 3 or 4 chronic kidney disease. Medicine (Baltimore) (2014) 0.87
Effect of a low-protein diet supplemented with ketoacids on skeletal muscle atrophy and autophagy in rats with type 2 diabetic nephropathy. PLoS One (2013) 0.80
Identification of a Proteinaceous Component in the Leaf of Moringa Oleifera lam. with Effects on High Serum Creatinine. Indian J Pharm Sci (2014) 0.77
Efficacy of the Essential Amino Acids and Keto-Analogues on the CKD progression rate in real practice in Russia - city nephrology registry data for outpatient clinic. BMC Nephrol (2016) 0.77
The effect of ONCE Renal on minerals and electrolytes in predialysis patients with chronic kidney disease. Int J Nephrol Renovasc Dis (2016) 0.75
Superior patient survival for continuous ambulatory peritoneal dialysis patients treated with a peritoneal dialysis fluid with neutral pH and low glucose degradation product concentration (Balance). Perit Dial Int (2005) 3.03
Changes in causative organisms and their antimicrobial susceptibilities in CAPD peritonitis: a single center's experience over one decade. Perit Dial Int (2004) 2.13
Intratympanic steroid injection for Bell's palsy: preliminary randomized controlled study. Otol Neurotol (2014) 2.00
Immediate initiation of CAPD following percutaneous catheter placement without break-in procedure. Perit Dial Int (2007) 1.95
Improving outcome of CAPD: twenty-five years' experience in a single Korean center. Perit Dial Int (2007) 1.83
Changing prescribing practice in CAPD patients in Korea: increased utilization of low GDP solutions improves patient outcome. Nephrol Dial Transplant (2006) 1.63
Frequencies of hepatitis B and C infections among haemodialysis and peritoneal dialysis patients in Asia-Pacific countries: analysis of registry data. Nephrol Dial Transplant (2008) 1.55
Risk factors for adverse outcomes after peritonitis-related technique failure. Perit Dial Int (2008) 1.54
Changing prevalence of glomerular diseases in Korean adults: a review of 20 years of experience. Nephrol Dial Transplant (2009) 1.53
Association of inflammation and protein-energy wasting with endothelial dysfunction in peritoneal dialysis patients. Nephrol Dial Transplant (2009) 1.50
Production of branched-chain alkylprodiginines in S. coelicolor by replacement of the 3-ketoacyl ACP synthase III initiation enzyme, RedP. Chem Biol (2005) 1.50
Factors associated with aortic stiffness and its change over time in peritoneal dialysis patients. Nephrol Dial Transplant (2010) 1.46
Renal transplantation in sensitized recipients with positive luminex and negative CDC (complement-dependent cytotoxicity) crossmatches. Transpl Int (2012) 1.40
Autoantibodies against phospholipase A2 receptor in Korean patients with membranous nephropathy. PLoS One (2013) 1.37
Red blood cell distribution width is an independent predictor of mortality in acute kidney injury patients treated with continuous renal replacement therapy. Nephrol Dial Transplant (2011) 1.34
The clinical usefulness of peritoneal dialysis fluids with neutral pH and low glucose degradation product concentration: an open randomized prospective trial. Perit Dial Int (2008) 1.34
Clinical characteristics of dialysis related sclerosing encapsulating peritonitis: multi-center experience in Korea. Yonsei Med J (2005) 1.32
Incidence and outcomes of contrast-induced nephropathy after computed tomography in patients with CKD: a quality improvement report. Am J Kidney Dis (2010) 1.31
New automated hepatitis C virus (HCV) core antigen assay as an alternative to real-time PCR for HCV RNA quantification. J Clin Microbiol (2010) 1.25
Clinical features and outcomes of IgA nephropathy with nephrotic syndrome. Clin J Am Soc Nephrol (2012) 1.21
Reduced residual renal function is a risk of peritonitis in continuous ambulatory peritoneal dialysis patients. Nephrol Dial Transplant (2007) 1.19
Plasma levels of soluble receptor for advanced glycation end products (sRAGE) and proinflammatory ligand for RAGE (EN-RAGE) are associated with carotid atherosclerosis in patients with peritoneal dialysis. Atherosclerosis (2011) 1.16
An increase in red blood cell distribution width from baseline predicts mortality in patients with severe sepsis or septic shock. Crit Care (2013) 1.14
Uric acid is associated with the rate of residual renal function decline in peritoneal dialysis patients. Nephrol Dial Transplant (2009) 1.11
Mortality and technique failure in peritoneal dialysis patients using advanced peritoneal dialysis solutions. Am J Kidney Dis (2009) 1.11
Generation of multiple bioactive macrolides by hybrid modular polyketide synthases in Streptomyces venezuelae. Chem Biol (2002) 1.10
Enhancement and selective production of phoslactomycin B, a protein phosphatase IIa inhibitor, through identification and engineering of the corresponding biosynthetic gene cluster. J Biol Chem (2003) 1.10
Small RNA sequencing reveals microRNAs that modulate angiotensin II effects in vascular smooth muscle cells. J Biol Chem (2012) 1.09
Effect of retinoic acid in experimental diabetic nephropathy. Immunol Cell Biol (2004) 1.08
Decreased circulating C3 levels and mesangial C3 deposition predict renal outcome in patients with IgA nephropathy. PLoS One (2012) 1.08
Cloning, sequencing, and characterization of the pradimicin biosynthetic gene cluster of Actinomadura hibisca P157-2. J Microbiol Biotechnol (2007) 1.07
Genome sequence of the plant growth-promoting rhizobacterium Bacillus sp. strain JS. J Bacteriol (2012) 1.06
Increasing home based dialysis therapies to tackle dialysis burden around the world: a position statement on dialysis economics from the 2nd Congress of the International Society for Hemodialysis. Nephrology (Carlton) (2011) 1.06
Long-term clinical outcomes of peritoneal dialysis patients: single center experience from Korea. Perit Dial Int (2008) 1.05
KNOW-CKD (KoreaN cohort study for Outcome in patients With Chronic Kidney Disease): design and methods. BMC Nephrol (2014) 1.04
Preservation of renal function by thyroid hormone replacement therapy in chronic kidney disease patients with subclinical hypothyroidism. J Clin Endocrinol Metab (2012) 1.04
Thyroid hormone replacement therapy attenuates the decline of renal function in chronic kidney disease patients with subclinical hypothyroidism. Thyroid (2013) 1.03
Intra-peritoneal interleukin-6 system is a potent determinant of the baseline peritoneal solute transport in incident peritoneal dialysis patients. Nephrol Dial Transplant (2010) 1.03
Renal outcomes in patients with type 2 diabetes with or without coexisting non-diabetic renal disease. Diabetes Res Clin Pract (2011) 1.03
Clinical implications of subclinical hypothyroidism in continuous ambulatory peritoneal dialysis patients. Am J Nephrol (2008) 1.02
Sclerosing encapsulating peritonitis as a complication of long-term continuous ambulatory peritoneal dialysis in Korea. Nephrology (Carlton) (2003) 1.02
Clinical implication of crescentic lesions in immunoglobulin A nephropathy. Nephrol Dial Transplant (2013) 1.02
IL-2/anti-IL-2 complex attenuates renal ischemia-reperfusion injury through expansion of regulatory T cells. J Am Soc Nephrol (2013) 1.01
Induction of heme oxygenase-1 protects against podocyte apoptosis under diabetic conditions. Kidney Int (2009) 1.00
Mortality of IgA nephropathy patients: a single center experience over 30 years. PLoS One (2012) 0.99
NF-kappaB inhibition radiosensitizes Ki-Ras-transformed cells to ionizing radiation. Carcinogenesis (2005) 0.99
Early catheter removal improves patient survival in peritoneal dialysis patients with fungal peritonitis: results of ninety-four episodes of fungal peritonitis at a single center. Perit Dial Int (2010) 0.99
Visceral fat thickness is associated with carotid atherosclerosis in peritoneal dialysis patients. Obesity (Silver Spring) (2011) 0.98
Nutrition in patients on peritoneal dialysis. Nat Rev Nephrol (2012) 0.98
Chryseobacterium kwangjuense sp. nov., isolated from pepper (Capsicum annuum L.) root. Int J Syst Evol Microbiol (2013) 0.98
Mortality and renal outcome of primary glomerulonephritis in Korea: observation in 1,943 biopsied cases. Am J Nephrol (2013) 0.98
Anti-apoptotic function of thymosin-beta in developing chick spinal motoneurons. Biochem Biophys Res Commun (2006) 0.97
TGF-β induces acetylation of chromatin and of Ets-1 to alleviate repression of miR-192 in diabetic nephropathy. Sci Signal (2013) 0.97
Report of the Asian Forum of Chronic Kidney Disease Initiative (AFCKDI) 2007. "Current status and perspective of CKD in Asia": diversity and specificity among Asian countries. Clin Exp Nephrol (2009) 0.97
MicroRNAs and the glomerulus. Exp Cell Res (2012) 0.97
Sulfatide-reactive natural killer T cells abrogate ischemia-reperfusion injury. J Am Soc Nephrol (2011) 0.97
Colchicine attenuates inflammatory cell infiltration and extracellular matrix accumulation in diabetic nephropathy. Am J Physiol Renal Physiol (2009) 0.95
The evolution of lupus activity among patients with end-stage renal disease secondary to lupus nephritis. Yonsei Med J (2004) 0.95
Usefulness of 23S rRNA amplification by PCR in the detection of bacteria in CAPD peritonitis. Am J Nephrol (2006) 0.95
Neopikromycin and novapikromycin from the pikromycin biosynthetic pathway of Streptomyces venezuelae. J Nat Prod (2006) 0.95
Activation of local aldosterone system within podocytes is involved in apoptosis under diabetic conditions. Am J Physiol Renal Physiol (2009) 0.95